Sequential Event Rate Monitoring.

Area of Science:

• Clinical Trials
• Biostatistics
• Statistical Monitoring

Background:

• Effective event rate monitoring is crucial for clinical trial statistical power and integrity, especially for time-to-event outcomes.
• Existing methods may not fully leverage advanced statistical theories for continuous monitoring.

Purpose of the Study:

• To introduce Sequential Event Rate Monitoring (SERM), a novel approach for continuous event rate monitoring in clinical trials.
• To demonstrate the practical implementation and benefits of SERM using theoretical advancements.

Main Methods:

• SERM utilizes the Sequential Probability Ratio Test (SPRT) with enhanced boundaries based on the nonlinear renewal theorem.
• Decision boundaries are derived from simple formulas, facilitating ease of implementation.
• The method operates on blinded data, preserving study integrity across various designs.

Main Results:

• SERM provides a practical and efficient method for continuous event rate monitoring.
• Real-world data from a Phase III trial illustrated SERM's potential for rapid assessment.
• The method maintains statistical accuracy (Type I and II errors) even with slow patient accrual.

Conclusions:

• SERM is a robust tool for enhancing clinical trial monitoring and enabling timely decision-making.
• Its ease of implementation, data efficiency, and broad applicability make it valuable for diverse clinical settings.
• This approach represents the first practical application of advanced renewal theorem concepts in clinical trial monitoring.